CONTEXT AND OBJECTIVE: Impaired local cell immunity seems to contribute towards the pathogenesis and progression of cervical intraepithelial neoplasia (CIN), but the underlying molecular mechanisms promoting its progression remain unclear. Identification of new molecular markers for prognosis and diagnosis of early-stage CIN may aid in decreasing the numbers of CIN cases. Several novel immunoregulatory molecules have been discovered over the past few years, including the human leukocyte antigen G (HLA-G), which through interaction with its receptors exerts important tolerogenic functions. Several lines of evidence suggest that T-helper interleukin-17 (IL-17)-producing cells (Th17 cells) may play a role in antitumor immunity. However, recent reports have implicated Th17 cells and their cytokines in both pro and anti-tumorigenic processes. The aim of the study was to evaluate the roles of HLA-G and Th17 in the immunopathogenesis of CIN I. DESIGN AND SETTING: Analytical cross-sectional study with a control group using 58 cervical specimens from the files of a public university hospital providing tertiary-level care.
INTRODUCTION

Impaired local cell immunity contributes towards the pathogenesis and progression of cervical intraepithelial neoplasia (CIN).
The mechanism of progression from CIN to cancer has not been well explained, but intensive research has been conducted in an attempt to discover which molecules of the immune system are involved in this process, since they are known to have a very important role. 1 Human leukocyte antigen G (HLA-G) is a non-classical class I molecule, which can be present both in membrane-bound and in soluble form, and it has been well recognized as a tolerogenic molecule, inhibiting both innate and adaptive immune responses. 2 Under physiological conditions, HLA-G expression has limited distribution, occurring particularly in cytotrophoblast cells, where it contributes towards fetal-maternal tolerance. 3 However, HLA-G expression may be induced under several pathological conditions, including malignant lesions, allografts and inflammatory and autoimmune disorders. 4 Recently, studies have provided evidence that the tolerogenic protein HLA-G shows aberrant expression in a variety of cancers, and it has been suggested that this is a mechanism for tumor escape from immunosurveillance. Within the context of cervical cancer, HLA-G expression has been correlated with disease progression in patients with cervical cancer. However, the role of HLA-G in cervical premalignant and malignant lesions has not been defined clearly. 5 Th17 cells have been characterized as interleukin (IL)-17-producing CD4(+) T cells that also produce IL-21, IL-22, and IL-26. 6 Greater numbers of IL-17-producing cells have also been found both in peripheral blood and in tumor tissues from cancer patients at advanced stages. 7 Although these data suggest that T-helper 17 (Th17) cells potentially have an impact on tumors, the nature and role of Th17 cells in the progression of cervical cancer remain unknown. The presence of HLA-G in CIN patients has been correlated with a worse prognosis and less chance of survival, but the cervical expression of HLA-G and IL-17 has not been evaluated.
In the present study, the possible role of HLA-G and IL-17 in the pathogenesis and progression of cervical lesions was investigated.
We measured HLA-G and IL-17 expression and correlated their levels in CIN I and chronic cervicitis (CC) patients with the clinical and pathological features, by means of immunohistochemistry.
This study may help in understanding the possible roles of coexpression of HLA-G and IL-17 in the progression of cervical lesions.
OBJECTIVES
The aim of this study was to assess the expression of human leukocyte antigen-G and interleukin-17 in cervical intraepithelial neoplasia.
METHODS
Patients
The 
Immunohistochemistry
Sections of thickness 3 µm were cut, placed on organosilanepretreated slides, and subjected to immunohistochemical assay using two monoclonal antibodies: 5A6G7 (EXBIO, Vestec, Czech
Republic) against soluble HLA-G5, diluted at 1:50; and ebio-65DEC17 (Ebioscience, San Diego, California, USA), which reacts with human IL-17A, diluted at 1:100. The cervical specimens were dewaxed in xylene, rehydrated in a graded alcohol series and rinsed in water. For antigen retrieval, the sections were immersed in 10 mM sodium citrate buffer (pH 6.2). Endogenous peroxidase blocking was performed using 3% hydrogen peroxide.
Nonspecific binding was performed using 3% low-fat dried milk 
Statistical analysis
The chi-square test or Fisher's exact test was used to test for asso- The statistical analyses were conducted using the GraphPad
InStat software (San Diego, California, USA) or R version 2.12.2.
Tests yielding P-values < 0.05 were considered significant.
RESULTS
Characteristics of the study population
The clinical and pathological variables of the participants studied are shown according to histological group in Table 3 .
The average ages of the CC and CIN I patients were 38.21 years (standard deviation, SD = 14.43) and 33.02 years (SD = 10.61), respectively. In both groups, the majority of the participants were non-Caucasian and had completed high school. The CC and CIN I patients were comparable regarding their age at first sexual intercourse and the number of sexual partners during their lifetimes, but CIN I cases were more likely to have had a higher number of sexual partners during their lifetimes. In relation to cigarette smoking and alcohol use, both groups showed a few users. CC patients were likely to be regular users of contraceptive methods.
Histology
In the present study Chi-square test for independent samples, P = 0.1604. CC = chronic cervicitis; CIN = cervical intraepithelial neoplasia. Chi-square test for independent samples, P = 0.2735. CC = chronic cervicitis; CIN = cervical intraepithelial neoplasia.
Expression of HLA-G and IL-17 in cervical precursor lesions
To explore whether HLA-G and IL-17 might be involved in the CIN cases, we first examined whether HLA-G and IL-17
were present in cervical specimens. In the whole group, HLA-G expression was observed in the control group, as shown in Figures 1 and 2 , and in Table 4 .
After adjustment for other covariables, the occurrences of HLA-G were significant (P-value = 0.04), with odds ratio (OR) estimated as 6.61 (95% confidence interval, CI: 1.22-49.55). This indicated that the odds of having CIN I (compared with CC) was 6.61 times greater (or 661% greater) for women who expressed HLA-G than for those who did not. Age was the only other significant predictor, after adjustment for other covariables, with an OR of 0.87 (95% CI: 0.75-0.96, P-value = 0.02), thus indicating a protective effect. In other words, the older the patient was, the smaller the odds of having CIN I also were. None of the other covariables were significant ( Table 5) .
HLA-G expression was primarily detected in the epithelial cells, fibroblasts and lymphocytes, and a standard dial-type cytoplasmic membrane was maintained. HLA-G was strongly expressed in trophoblastic slices that were used as positive controls, while HLA-G expression was not found in any specimens obtained from healthy controls.
DISCUSSION
Cervical squamous intraepithelial lesions are a precancerous stage of cervical cancer. 12 The mechanism that promotes the progression of cervical lesions has not been clearly explained, but the immune response appears to be an important factor. 5 Therefore, identification of new molecular markers to improve clinical diagnosing of early-stage cervical lesions is still necessary and may enable more effective evaluation of patients with early-stage lesions, thereby resulting in slower progression of these lesions.
In the cervical context, Guimarães et al. reported that HLA-G expression was low in cervical cancer specimens. 13 On the other hand, Zheng et al. reported that HLA-G is abundantly expressed in premalignant and malignant cervical intraepithelial lesions. 5 Thus, our study found that HLA-G expression was a significant predictor in relation to CIN I and age, such that overall, HLA-G was present in approximately 75.86% of the cases and was primarily detected in epithelial cells, fibroblasts and lymphocytes.
The presence of HLA-G was not influenced by other factors, such as sex, ethnicity, number of partners during lifetime, parity and oral contraceptive use. This suggests that the HLA-G molecule could be associated with the progression of cervical lesions.
In addition, polymorphic sites of HLA-G genes in cervical lesions and cancer have been studied. In high-grade and invasive cervicovaginal cancer patients, the 14 base pair (bp) In/In polymorphism seems to be associated with greater development of invasive cervical cancer.
14 On the other hand, spontaneous demethylation events in the HLA-G promoter do not play a primary role in promoting escape from immunosurveillance, in relation to development of precancerous cervical lesions. 15 To our knowledge, the present study is the first to explore Many studies have discussed the role of HLA-G and IL-17 in various types of cancer. 16, 20 However, this is the first study 
